Skip to main content
Concord Enviro Systems Limited logo

Concord Enviro Systems Limited — Investor Relations & Filings

Ticker · CEWATER ISIN · INE037Z01029 LEI · 335800W1DA98MHPPX329 BSE.NS Water supply; sewerage, waste management and remediation activities
Filings indexed 155 across all filing types
Latest filing 2025-02-13 Regulatory Filings
Country IN India
Listing BSE.NS CEWATER

About Concord Enviro Systems Limited

https://www.concordenviro.in/

Concord Enviro Systems Limited is an environmental engineering firm specializing in advanced water and wastewater treatment and recycling solutions. The company provides integrated systems designed to manage complex industrial effluents, focusing on Zero Liquid Discharge (ZLD) and resource recovery. Its core technology portfolio includes membrane-based processes such as reverse osmosis, ultrafiltration, and nanofiltration, alongside thermal evaporation and crystallization systems. Concord Enviro serves a diverse range of industrial sectors, including pharmaceuticals, chemicals, textiles, and food and beverage, helping clients meet stringent environmental regulations while optimizing water consumption. By leveraging proprietary engineering designs and technical expertise, the company delivers end-to-end solutions from process design and equipment manufacturing to installation and long-term operation and maintenance.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the decision to close business operations of a step-down subsidiary. It includes details required under SEBI regulations about the subsidiary's turnover, net worth, and closure timeline. There is no financial report or detailed financial statements presented, nor is it an announcement of earnings or management changes. The document is a regulatory announcement about a corporate event (closure of subsidiary operations) and complies with listing obligations disclosure requirements. The document length is 3775 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-02-13 English
Integrated Filing- Financial
Regulatory Filings
2025-02-13 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended December 31, 2024' and is addressed to stock exchanges, referencing SEBI regulations related to listing obligations and disclosure requirements. It contains detailed information about the utilization of IPO proceeds, including financial figures, certifications, and comments from the monitoring agency and the issuer's board. The report is comprehensive, covering the quarter ended December 31, 2024, and includes substantive financial data and analysis related to the use of funds raised through the IPO. This fits the definition of a regulatory monitoring report on capital utilization post-IPO, which is a type of Capital/Financing Update. It is not an announcement of a report publication but the report itself, given its length (15,000 characters) and detailed content. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-02-13 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the statement of deviation or variation in the utilization of funds raised through an Initial Public Offer (IPO) for the quarter ended December 31, 2024. It references compliance with SEBI regulations and circulars, and includes a statement that there was no deviation or variation in the use of IPO proceeds. The document includes an annexure with detailed information on the utilization of funds and confirms audit committee and board approval. The content is regulatory in nature, reporting compliance and fund utilization status rather than presenting financial statements or detailed financial performance. The document length is about 4856 characters, which is relatively short and primarily serves as an official regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS) as a compliance announcement rather than a full financial report or earnings release.
2025-02-13 English
Financial Result Updates
Regulatory Filings
2025-02-13 English
Outcome of Board Meeting
Regulatory Filings
2025-02-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.